Synapse Drugs Private Limited - Company Profile

It is a infrastructure and utilities private limited company based in Secunderabad, Telangana, India, established in 2014.
2014 Secunderabad, Telangana, India Under Process Of Striking Off
Last Updated:
Access Report
About Synapse Drugs Private Limited

Synapse Drugs Private Limited, a under process of striking off private limited company, was established on 03 December 2014 in Secunderabad, Telangana, India. Engaging in general construction services within the manufacturing sector, it holds CIN: U24232TG2014PTC096661. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sucharitha Vala (Director), Niranjanrao Janardhanrao Errabelli (Director), Venkata Narasimha Rao Vala (Director). Past directors included Sucharitha Vala, Niranjanrao Janardhanrao Errabelli. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No. 1-8-309/1, Flat No. 205 Lake View Residency, Patigadda, Secunderabad, Telangana, 500003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2014PTC096661

  • Registration Number

    096661

  • Incorporation Date

    03 December 2014

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Under Process Of Striking Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth ****
  • Total Assets **** 11.61%
Company report

Synapse Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Synapse Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synapse Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Sucharitha Vala Director 01 May 2019 Current
Niranjanrao Janardhanrao Errabelli Director 03 Dec 2014 Current
Venkata Narasimha Rao Vala Director 03 Dec 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 26 Sep 2019 Past
Pramod Abcsdd Director 08 Nov 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synapse Drugs.

Synapse Drugs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Synapse Drugs revenue growth over time
Synapse Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 11.61%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synapse Drugs?

In 2019, Synapse Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Synapse Drugs?

Unlock and access historical data on people associated with Synapse Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synapse Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synapse Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synapse Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Synapse Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Synapse Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Director Appointment

    Sucharitha Vala was appointed as a Director was appointed as a Director on 01 May 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Niranjanrao Janardhanrao Errabelli was appointed as a Director was appointed as a Director on 03 Dec 2014 & has been associated with this company since 11 years 3 months . was completed.

  • Director Appointment

    Venkata Narasimha Rao Vala was appointed as a Director was appointed as a Director on 03 Dec 2014 & has been associated with this company since 11 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Synapse Drugs Private Limited was registered on 03 Dec 2014 with Roc Hyderabad & aged 11 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synapse Drugs Private Limited?

The CIN of Synapse Drugs Private Limited is U24232TG2014PTC096661.

Where is Synapse Drugs Private Limited headquartered?

Synapse Drugs Private Limited is headquartered at H.No. 1-8-309/1, Flat No. 205 Lake View Residency, Patigadda, Secunderabad, Telangana, 500003.

When was Synapse Drugs Private Limited incorporated?

Synapse Drugs Private Limited was incorporated on 03 December 2014.

Who are the current directors of Synapse Drugs Private Limited?

The current directors of Synapse Drugs Private Limited are

What is the primary industry of Synapse Drugs Private Limited?

The primary industry of Synapse Drugs Private Limited is Manufacturing.

Is Synapse Drugs Private Limited a listed company?

Synapse Drugs Private Limited is unlisted.

What is the capital structure of Synapse Drugs Private Limited?

The authorized capital of Synapse Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Synapse Drugs Private Limited?

The compliance status of Synapse Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available